, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th 2. Costs of sales and gross profit Costs of sales were Baht 117 .60 million in the first nine months of 2019, a surge of Baht 32 .42 million
the gross profit margin was 7.26%. Due to the average cost of raw material was lower than the market price. 3. Selling expenses was Baht 36.79 million which increased Baht 3.58 Million or increased
equivalent to (1%) in 2019 comparing to the previous year. Total Expenses: An increase by 2% of expenses from the year before mainly affected by the new law regarding employee benefit which has been effective
Committee as follows : - a compensation of the benefit received from committing the offense in an amount of 1,930,300.00 Baht - a civil
compensation of the benefit received from committing the offense in an amount of 961,202.00 Baht - a civil monetary penalty of 1,201,502.50 Baht  
of the benefit received from committing the offense in an amount of 9,954.00 Baht - a civil monetary penalty of 500,000.00 Baht - a
. Report Name Data File As of Data Definition 1 Mutual fund fees and expenses June/2023 2 Mutual fund fees and expenses May/2023 3 Mutual fund fees and expenses April/2023 4 Mutual fund fees and
decreased Baht 102.05 million – resulting to the gross profit margin was increased to 7.53% from 6.56% of year 2018. 2. Selling expenses was Baht 144.14 million which increased Baht 12.71 Million or increased
increase due to the fluctuation of raw material price that remain high during our financial year. The direction of raw material price started to decline at the end of financial year and expects to benefit
Baht 0.83 million; - the record of additional provision for long-term employee benefit of Baht 4.58 million (as shown under Administrative Expenses) to comply with the latest Labor Protection Act